# Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

> **NCT06632327** · PHASE3 · RECRUITING · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 1100 (estimated)

## Conditions studied

- Resectable Lung Non-Small Cell Carcinoma
- Stage II Lung Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIB Lung Cancer AJCC v8

## Interventions

- **PROCEDURE:** Surgical Procedure
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Pemetrexed
- **DRUG:** Gemcitabine
- **DRUG:** Docetaxel
- **DRUG:** Vinorelbine
- **DRUG:** Nivolumab
- **DRUG:** Pembrolizumab
- **DRUG:** Atezolizumab
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT06632327
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2029-04-30
- **Final completion:** 2030-04-30
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06632327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06632327, "Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06632327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*